Assessing the solubility of silicon dioxide particles using simulated lung fluid"

Open Toxicology Journal

Volumn 4, Issue , 2010, Pages 51-55

  Larson, Rodney R ^a   Story, Scott G ^a   Hegmann, Kurt T ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; COPD; Heart disease; Kidney disease; Lung cancer; Lung fluids; Particles; Silicon dioxide; Solubility; Toxicity

Indexed keywords

SILICON DIOXIDE;

ARTICLE; BIOLOGY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISSOLUTION; EXPOSURE; EXTRACELLULAR SPACE; INTRACELLULAR SPACE; LUNG FLUID; MASS; PARTICLE SIZE; PATHOGENESIS; PH; PRIORITY JOURNAL; SAMPLE; SILICOSIS; SIMULATION; SOLUBILITY;

EID: 80555139067     PISSN: None     EISSN: 18743404     Source Type: Journal    
DOI: 10.2174/1874340401004010051     Document Type: Article

References (27)

1. Rice FL, Park R, Stayner L, Smith R, Gilbert S, Checkoway H. Crystalline silica exposure and lung cancer mortality in diatomaceous earth industry workers: a quantitative risk assessment. Occup Environ Med 2001; 58: 38-45.
2. Dufresne A, Begin R, Dion C, et al. Angular and fibrous particles in lung in relation to silica-induced diseases. Int Arch Occup Environ Health 1998; 71: 263-9.
3. Saffiotti U, Lambert DN, Mao Y, Shi X, Williams AO, Kaighn ME. mechanism of carcinogenesis by crystalline silica in relation to oxygen radicals. Environ Health Perspect 1994; 102(Suppl 10): 159-3.
4. National Institute for Occupational Safety and Health (US). Health Effects of Occupational Exposure to Respirable Crystalline Silica. Department of Health and Human Services Centers for Disease Control and Prevention. DHHS (NIOSH) Publication No. 2002- 129; April 2002.
5. Steenland K, Sanderson W. Lung cancer among industrial sand workers exposed to crystalline silica. Am J Epidemiol 2001; 153: (Stud Report).
6. McDonald JC, McDonald AD, Hughes JM, Rando RJ, Weill H. Mortality from lung and kidney disease in a cohort of North American industrial sand workers: an update. Ann Occup Hyg 2005; 49(5): 367-73.
7. Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003; 60(2): 122-9.
8. Steenland K, Sanderson W, Calvert GM. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology 2001; 12(4): 405-12.
9. Steenland K. One agent, many diseases: exposure-response data and comparative risks of different outcomes following silica exposure. Am J Ind Med 2005; 48(1): 16-23.
10. Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999; 107(Suppl 5): 793-802.
11. Erdogdu G, Hasirci V. An overview of the role of mineral solubility in silicosis and asbestosis. Environ Res 1998; 78: 38-42.
12. Silicosis Fact Sheet. N238. World Health Organization, May 2000. Accessed March5, 2010. Available from: www.who.int/mediacentre/factsheets/fs238/en/
13. Maciejewska A. Occupational exposure assessment for crystalline silica dust: approach in Poland and worldwide. Int J Occup Med Environ Health 2008; 21(1): 1-23.
14. Center for Disease Control and Prevention (US). Silicosis mortality, prevention, and control. MMWR Morb Mortal Wkly Rep 2005; 54: 16.
15. Johnson NF. Phagosomal pH and glass fiber dissolution in cultured nasal epithelial cells and alveolar macrophages: a preliminary study. Environ Health Perspect 1994; 102(Suppl 5): 97-103.
16. Nilsen A, Nyberg K, Camner P. Intraphagosomal pH in alveolar macrophages after phagocytosis in vivo and in vitro of fluorescein-labeled yeast particles. Exp Lung Res 1988; 14: 197-207.
17. Nyberg K, Johansson U, Johansson A, Camner P. Phagolysosomal pH in alveolar macrophages. Environ Health Perspect 1992; 97: 149-52.
18. Kreyling WG. Intracellular particle dissolution in alveolar macrophages. Environ Health Perspect 1992; 97: 121-6.
19. Lundborg M, Johard U, Johansson A, et al. Phagolysosomal morphology and dissolution of cobalt oxide particles by human and rabbit alveolar macrophages. Exp Lung Res 1995; 21: 51-66.
20. Guthrie GD Jr. Mineral properties and their contributions to particle toxicity. Environ Health Perspect 1997; 105: 1003-9.
21. Christensen SR, Jensen SL, Guldberg M, Kamstrup O. Effect of chemical composition of man-made vitreous fibers on the rate of dissolution in vitro at different pHs. Environ Health Perspect 1994; 102: 83-6.
22. Mattson SM. Glass fiber dissolution in simulated lung fluid and measures needed to improve consistency and correspondence to in vivo dissolution. Environ Health Perspect 1994; 102: 87-90.
23. Thelohan S, de Meringo A. In vitro dynamic solubility test: influence of various parameters. Environ Health Perspect 1994; 102: 91-6.
24. Kanapilly GM, Raabe OG, Goh CHT, Chimenti RA. Measurement of in vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower respiratory tract after inhalation. Health Phys 1973; 24: 497-507.
25. Baillif P, Touray JC. Chemical behavior of aluminum and phosphorus during dissolution of glass fibers in physiological saline solutions. Environ Health Perspect 1994; 102: 77-81.
26. Midlander K, Wallinder IO, Leygraf C. In vitro studies of copper release from powder particles in synthetic biological media. Environ Pollut 2007; 145, 1: 51-9.
27. De Meringo A, Morscheidt C, Thelohan S, Tiesler H. In vitro assessment of biodurability: acellular systems. Environ Health Perspect Suppl 1994;102: S5.